Curcumin in combination with herceptin decreased levels of NF-κB in a dose-dependent manner in HER-2-overexpressed breast cancer cells, overcoming herceptin resistance (Lai et al., 2012). This evidence concerns the gene NFKB1 and breast carcinoma.